HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monden, Y. Articles by Kawashima, Y. Search for Related Content PubMed PubMed Citation Articles by Monden, Y. Articles by Kawashima, Y.

The Annals of Thoracic Surgery, Vol 38, 287-291, Copyright © 1984 by The Society of Thoracic Surgeons

ARTICLES

Effects of preoperative duration of symptoms on patients with myasthenia gravis

Y Monden, K Nakahara, K Kagotani, Y Fujii, S Nanjo, A Masaoka and Y Kawashima

In 80 patients with type II nonthymomatous myasthenia gravis who underwent extended thymectomy, we investigated preoperative duration of symptoms, prognosis after thymectomy, immunological findings, and germinal center formation in the thymus. Our findings included the following. First, the palliation rate after thymectomy ranged from 73 to 100% and was independent of the preoperative duration of symptoms. The remission rate was high in patients with a short preoperative duration. Second, the lymphocyte count of peripheral blood decreased as preoperative duration increased. Third, the percentage of positive reactions to purified protein derivative of tuberculin decreased as preoperative duration increased: 100% in the one-year group, 78% in the two-year group, 75% in the three-year group, and 56% in the four-year group. Fourth, the degree of germinal center formation in the thymus was higher in patients with a longer preoperative duration. The correlation between germinal center formation and preoperative duration was significant. Finally, the T-cell population in peripheral blood and immunoglobulin, and antibody to acetylcholine receptor in serum, had no significant relationship with the preoperative duration of myasthenia gravis.

This article has been cited by other articles:

				H. Kattach, K. Anastasiadis, J. Cleuziou, C. Buckley, B. Shine, R. Pillai, and C. Ratnatunga Transsternal Thymectomy for Myasthenia Gravis: Surgical Outcome Ann. Thorac. Surg., January 1, 2006; 81(1): 305 - 308. [Abstract] [Full Text] [PDF]

				G. S. Gronseth and R. J. Barohn Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, July 12, 2000; 55(1): 7 - 15. [Full Text] [PDF]

				M. Tsuchida, Y. Yamato, T. Souma, K. Yoshiya, T. Watanabe, T. Aoki, and J.-i. Hayashi Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis Ann. Thorac. Surg., June 1, 1999; 67(6): 1563 - 1567. [Abstract] [Full Text] [PDF]

				A. Masaoka, Y. Yamakawa, H. Niwa, I. Fukai, S. Kondo, M. Kobayashi, Y. Fujii, and Y. Monden Extended Thymectomy for Myasthenia Gravis Patients: A 20-Year Review Ann. Thorac. Surg., September 1, 1996; 62(3): 853 - 859. [Abstract] [Full Text]

				H. Nakamura, Y. Taniguchi, Y. Suzuki, Y. Tanaka, K. Ishiguro, M. Fukuda, H. Hara, and T. Mori DELAYED REMISSION AFTER THYMECTOMY FOR MYASTHENIA GRAVIS OF THE PURELY OCULAR TYPE J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 371 - 375. [Abstract] [Full Text]